NCT07522320Active, not recruiting
Costs of Opportunistic Upper Gastrointestinal Endoscopy and the Economic Burden of Gastric Cancer Management
Real-world Incremental Costs of Opportunistic Upper Gastrointestinal Endoscopy Added to Colorectal Cancer Screening and the Economic Burden of Gastric Cancer Management: a Retrospective Cohort Study - Study Protocol
Source: ClinicalTrials.gov · Last updated 20 Jul 2026
Brief summary (registry, in English)
Data will be extracted from routinely collected hospital databases.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 250 (estimated)
- First submitted
- 27 Mar 2026
- Start date
- 2 Jan 2026
- Primary completion date
- 21 Jul 2026
- Lead sponsor
- Unidade Local De Saúde Do Norte Alentejano
- NCT number
- NCT07522320
What you commit to
- Study type: Observational
- Planned participants: 250
- From 2 Jan 2026 to the primary completion date, 21 Jul 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Exclusion criteria included a prior diagnosis of gastric cancer, as well as any condition that would prevent the safe performance of the EGD or the collection of gastric mucosal biopsies. Previous EGD was not listed as an exclusion criterion.
- Cohort B:
Other illness
- Gastric involvement from metastatic disease of another primary tumor.
Other
- Cohort A:
- Other types of gastric tumors.
Who the study is looking for
- Cohort A:
- Eligible participants were adults aged 50 to 75 years or older who had been referred for colonoscopy as part of the national colorectal cancer screening programme, following a positive FIT. To be included, individuals also needed to provide informed consent and agree to undergo an EGD endoscopy for the screening of potential upper gastrointestinal precancerous conditions or lesions.
- Cohort B:
- Patients with gastric adenocarcinoma, diagnosed and treated at Unidade Local de Saúde do Alto Alentejo between 2015 and 2025.
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Unidade Local de Saúde do Alto Alentejo Coordinator of this site? Confirm its status | Portalegre | Portugal | Unknown status |
Related publications
This page is information, not medical advice. Discuss any trial with your doctor.